Target Price | €44.88 |
Price | €32.05 |
Potential |
40.03%
register free of charge
|
Number of Estimates | 7 |
7 Analysts have issued a price target Dermapharm 2026 .
The average Dermapharm target price is €44.88.
This is
40.03%
register free of charge
€50.40
57.25%
register free of charge
€34.34
7.15%
register free of charge
|
|
A rating was issued by 11 analysts: 8 Analysts recommend Dermapharm to buy, 3 to hold and 0 to sell. | |
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
Analyst Estimates: Analysts believe that the Dermapharm stock has an average upside potential 2026 of
40.03%
register free of charge
|
Dec '24 |
2025 Estimates |
|
---|---|---|
Revenue Billion € | 1.18 | 1.19 |
4.00% | 1.04% | |
EBITDA Margin | 25.91% | 27.81% |
2.54% | 7.31% | |
Net Margin | 9.64% | 10.43% |
75.43% | 8.23% |
7 Analysts have issued a sales forecast Dermapharm 2025 . The average Dermapharm sales estimate is
This results in the following potential growth metrics:
6 Analysts have issued an Dermapharm EBITDA forecast 2025. The average Dermapharm EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
7 Dermapharm Analysts have issued a net profit forecast 2025. The average Dermapharm net profit estimate is
This results in the following potential growth metrics and future Net Margins:
Dec '24 |
2025 Estimates |
|
---|---|---|
Earnings Per Share € | 2.11 | 2.31 |
81.90% | 9.48% | |
P/E | 13.87 | |
EV/Sales | 2.16 |
7 Analysts have issued a Dermapharm forecast for earnings per share. The average Dermapharm EPS is
This results in the following potential growth metrics and future valuations:
Analyst | Rating | Action | Date |
---|---|---|---|
BERENBERG |
Locked
➜
Locked
|
Locked | Sep 11 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Sep 09 2025 |
ODDO BHF |
Locked
➜
Locked
|
Locked | Sep 05 2025 |
PARETO SECURITIES AS |
Locked
➜
Locked
|
Locked | Sep 01 2025 |
MWB RESEARCH AG |
Locked
➜
Locked
|
Locked | Aug 27 2025 |
WARBURG RESEARCH GMBH |
Locked
➜
Locked
|
Locked | Aug 26 2025 |
JEFFERIES |
Locked
➜
Locked
|
Locked | Aug 26 2025 |
Analyst Rating | Date |
---|---|
Locked
BERENBERG:
Locked
➜
Locked
|
Sep 11 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Sep 09 2025 |
Locked
ODDO BHF:
Locked
➜
Locked
|
Sep 05 2025 |
Locked
PARETO SECURITIES AS:
Locked
➜
Locked
|
Sep 01 2025 |
Locked
MWB RESEARCH AG:
Locked
➜
Locked
|
Aug 27 2025 |
Locked
WARBURG RESEARCH GMBH:
Locked
➜
Locked
|
Aug 26 2025 |
Locked
JEFFERIES:
Locked
➜
Locked
|
Aug 26 2025 |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.